These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25947158)

  • 21. Clinical consequences of antiphospholipid antibodies.
    Derksen RH; de Groot PG
    Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obstetric antiphospholipid syndrome: has the black swan swallowed a red herring?
    Clark CA; Spitzer KA; Laskin CA
    J Rheumatol; 2015 Feb; 42(2):155-7. PubMed ID: 25641965
    [No Abstract]   [Full Text] [Related]  

  • 23. Do low-risk pregnant women with antiphospholipid antibodies need to be treated? Organizing Group of the Antiphospholipid Antibody Treatment Trial.
    Cowchock S; Reece EA
    Am J Obstet Gynecol; 1997 May; 176(5):1099-100. PubMed ID: 9166175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies.
    Donohoe S; Quenby S; Mackie I; Panal G; Farquharson R; Malia R; Kingdom J; Machin S
    Lupus; 2002; 11(1):11-20. PubMed ID: 11898913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiphospholipid antibodies and pregnancy wastage.
    Christiansen OB; Lauritsen JG
    Hum Reprod; 1994 Jul; 9(7):1359-62. PubMed ID: 7962450
    [No Abstract]   [Full Text] [Related]  

  • 26. Obstetric antiphospholipid syndrome: lobsters only? Or should we also look for selected red herrings?
    Meroni PL; Chighizola CB; Gerosa M; Trespidi L; Acaia B
    J Rheumatol; 2015 Feb; 42(2):158-60. PubMed ID: 25641966
    [No Abstract]   [Full Text] [Related]  

  • 27. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombotic risk in the antiphospholipid syndrome.
    Lim W
    Semin Thromb Hemost; 2014 Oct; 40(7):741-6. PubMed ID: 25299926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and management for antiphospholipid syndrome].
    Kaburaki J; Kuwana M
    Rinsho Byori; 2000 May; 48(5):463-8. PubMed ID: 10892296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The 460th case: lower extremity edema, positive fecal occult blood].
    Sun YD; Zhao JL; Zhang P; Wang Q; Li MT
    Zhonghua Nei Ke Za Zhi; 2017 Dec; 56(12):974-976. PubMed ID: 29202544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiphospholipid antibodies: a threat throughout pregnancy.
    Hewell SW; Hammer RH
    J Obstet Gynecol Neonatal Nurs; 1997; 26(2):162-8. PubMed ID: 9087900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antiphospholipid syndrome and pregnancy].
    Gadó K; Domján G
    Orv Hetil; 2012 Aug; 153(31):1207-18. PubMed ID: 22846489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The stillbirth scandal.
    Hughes G
    Lupus; 2013 Jul; 22(8):759-60. PubMed ID: 23761097
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antiphospholipid antibodies as a cause of adverse pregnancy outcome. Therapeutic approach].
    Chernev T; Koleva R; Karag'ozova Zh; Chernev A
    Akush Ginekol (Sofiia); 2003; 42 Suppl 2():6-7. PubMed ID: 14619744
    [No Abstract]   [Full Text] [Related]  

  • 35. The antiphospholipid syndrome.
    Levine JS; Branch DW; Rauch J
    N Engl J Med; 2002 Mar; 346(10):752-63. PubMed ID: 11882732
    [No Abstract]   [Full Text] [Related]  

  • 36. Monitoring oral anticoagulation may require determination of single coagulation factor activities in patients with antiphospholipid syndrome.
    Sucker C; Wenzel F; Zotz RB; Hetzel GR; Scharf RE
    J Rheumatol; 2006 Sep; 33(9):1881-2. PubMed ID: 16881092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study between obstetric antiphospholipid syndrome and obstetric morbidity related with antiphospholipid antibodies.
    Alijotas-Reig J; Esteve-Valverde E; Ferrer-Oliveras R; LLurba E; Ruffatti A; Tincani A; Lefkou E; Bertero MT; Espinosa G; de Carolis S; Rovere-Querini P; Lundelin K; Picardo E; Mekinian A;
    Med Clin (Barc); 2018 Sep; 151(6):215-222. PubMed ID: 29274674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features and pregnancy outcome in antiphospholipid syndrome patients with history of severe pregnancy complications.
    Matsuki Y; Atsumi T; Yamaguchi K; Hisano M; Arata N; Oku K; Watanabe N; Sago H; Takasaki Y; Murashima A
    Mod Rheumatol; 2015 Mar; 25(2):215-8. PubMed ID: 25146551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiphospholipid syndrome: review.
    Sammaritano LR
    South Med J; 2005 Jun; 98(6):617-25; quiz 626-7, 645. PubMed ID: 16004169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What have we learned about antiphospholipid syndrome from patients and antiphospholipid carrier cohorts?
    Pengo V; Banzato A; Bison E; Bracco A; Denas G; Ruffatti A
    Semin Thromb Hemost; 2012 Jun; 38(4):322-7. PubMed ID: 22399307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.